Research Scientist
CurrentCancer therapeutics: Development of anti-cancer therapeutics that block the dimerization (activation) of the membrane receptor MUC1*. Development of cell based assays to determine the effect of anti-cancer therapeutics on growth rate of several types of cancers. Efficacy and toxicity studies in animals. Design, expression and purification of several engineered proteins of interest.Stem cells: Development of a xeno-free chemically defined media for the culture of embryonic stem cells and induced pluripotent stem cells. Expression and purification of a unique growth factor (NM23) that maintains its oligomerization state as a dimer, which is the only active form able to dimerize and activate the membrane receptor MUC1*. Development of a xeno-free surface that supports stem cells growth.